SensoDetect AB Logo

SensoDetect AB

Develops AI decision-support solutions for mental illness diagnostics.

SDET | SPGR

Overview

Corporate Details

ISIN(s):
SE0003037456 (+1 more)
LEI:
549300BPUMGJZ3N7QM92
Country:
Sweden
Address:
Arenagatan 31, 215 32 Malmö

Description

SensoDetect AB is a neurodiagnostics MedTech and artificial intelligence (AI) company that develops objective decision-support solutions for mental illness. Based on over 30 years of research in clinical psychoacoustics, the company's core technology analyzes Auditory Brainstem Response (ABR) signals to provide quantitative data on the brain's reaction to sound. This system is designed to assist healthcare professionals in the assessment of psychiatric disorders such as schizophrenia, ADHD, and autism, aiming to improve diagnostic accuracy and patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SensoDetect AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SensoDetect AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SensoDetect AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-22 Johan Granath Other Other 1,223,955 183,593.25 SEK
2025-01-21 per-anders hedin Other Other 3,214,285 482,142.75 SEK
2025-01-21 Johan Möllerström Other Other 2,170,535 325,580.25 SEK
2025-01-21 Johan Möllerström Other Other 1,836,610 275,491.50 SEK
2025-01-21 Johan Möllerström Other Other 714,285 107,142.75 SEK
2025-01-21 Wendi Ma Other Other 66,392 9,958.80 SEK
2025-01-21 Per-Anders Hedin Other Other 43,050 6,457.50 SEK
2025-01-21 Wendi Ma Other Other 66,392 N/A

Peer Companies

CAMBRIDGE COGNITION HOLDINGS PLC Logo
Develops digital solutions and a platform for CNS clinical trials to assess brain health.
United Kingdom
COG
A clinical-stage biopharmaceutical company developing novel cancer therapeutics.
Japan
4575
Captor Therapeutics S.A. Logo
Develops Targeted Protein Degradation therapies for cancer and autoimmune diseases.
Poland
CTX
Cardiff Oncology, Inc. Logo
A clinical-stage biotech developing cancer therapies that inhibit Polo-like kinase 1.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
Develops AI-powered epigenetic and genetic tests for early heart disease detection.
United States of America
CDIO
CASSAVA SCIENCES INC Logo
Clinical-stage biotech developing treatments for Central Nervous System disorders.
United States of America
SAVA
Celcuity Inc. Logo
Clinical-stage biotech developing targeted therapies for multiple solid tumors.
United States of America
CELC
Develops and manufactures cellulose-based nonwoven fabrics for the cosmetics sector.
South Korea
318160
CEL SCI CORP Logo
Clinical-stage biotech developing immunotherapies for cancer and infectious diseases.
United States of America
CVM
Celyad Oncology SA Logo
Biotechnology company developing innovative CAR-T cell therapies to treat cancer.
Belgium
CYAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.